AI technology developer Blackford will make several Coreline Soft AVIEW products for thoracic CT available through the Blackford platform.
Blackford will offer AVIEW LCS for identifying and assessing pulmonary nodules in lung cancer screening; AVIEW COPD for low attenuation area and high attenuation area analysis in chronic obstructive pulmonary disease (COPD); and AVIEW CAC, which scores coronary artery calcium deposits for risk stratification. All three are available in a bundle called AVIEW LCS Plus, according to Blackford.
AVIEW Lung Texture will also be available for evaluating interstitial lung diseases once it has been cleared by the U.S. Food and Drug Administration (FDA), Blackford noted.
